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Abstract
Background: Maternal and perinatal mortality are major problems for which progress in sub-
Saharan Africa has been inadequate, even though childbirth services are available, even in the
poorest countries. Reducing them is the aim of two of the main Millennium Development Goals.
Many initiatives have been undertaken to remedy this situation, such as the Advances in Labour and
Risk Management (ALARM) International Program, whose purpose is to improve the quality of
obstetric services in low-income countries. However, few interventions have been evaluated, in
this context, using rigorous methods for analyzing effectiveness in terms of health outcomes. The
objective of this trial is to evaluate the effectiveness of the ALARM International Program (AIP) in
reducing maternal mortality in referral hospitals in Senegal and Mali. Secondary goals include
evaluation of the relationships between effectiveness and resource availability, service organization,
medical practices, and satisfaction among health personnel.
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Methods/Design: This is an international, multi-centre, controlled cluster-randomized trial of a
complex intervention. The intervention is based on the concept of evidence-based practice and on
a combination of two approaches aimed at improving the performance of health personnel: 1)
Educational outreach visits; and 2) the implementation of facility-based maternal death reviews.
The unit of intervention is the public health facility equipped with a functional operating room. On
the basis of consent provided by hospital authorities, 46 centres out of 49 eligible were selected in
Mali and Senegal. Using randomization stratified by country and by level of care, 23 centres will be
allocated to the intervention group and 23 to the control group. The intervention will last two
years. It will be preceded by a pre-intervention one-year period for baseline data collection. A
continuous clinical data collection system has been set up in all participating centres. This, along
with the inventory of resources and the satisfaction surveys administered to the health personnel,
will allow us to measure results before, during, and after the intervention. The overall rate of
maternal mortality measured in hospitals during the post-intervention period (Year 4) is the
primary outcome. The evaluation will also include cost-effectiveness.
Trial Registration: The QUARITE trial is registered on the Current Controlled Trials website
under the number ISRCTN46950658 http://www.controlled-trials.com/.
Background
Maternal and perinatal mortality in sub-Saharan Africa
In sub-Saharan Africa, maternal and perinatal mortality
and morbidity are major problems for which progress has
been inadequate. Reducing them is the aim of two of the
Millennium Development Goals (MDG4 and MDG5)
whose attainment in this region of the world is very
unlikely [1]. The broad strategies that have made it possi-
ble to reduce maternal and perinatal mortality are known:
prenatal care, labour and delivery management by quali-
fied personnel, and availability of emergency obstetric
care (EmOC) [2]; however, their implementation is a
major challenge in sub-Saharan Africa, where healthcare
systems are fragile and still being developed. Service avail-
ability and quality of care in health facilities are very het-
erogeneous and most often inadequate [3-7]. According
to WHO, it will be important, over the next 10 years, to
update the skills of many professionals who do not cur-
rently have the competencies required to provide EmOC
[8]. In addition, among the trained professionals cur-
rently on staff, it is apparently difficult to maintain a high
level of performance in services that are often disorgan-
ized and under-equipped [9]. The lack of motivation leads
to a high level of staff turnover, with responsibilities then
falling on categories of staff that are less qualified [10].
In Mali and Senegal, the rates of maternal mortality esti-
mated by WHO in 2005 remain high: 970 and 980 mater-
nal deaths per 100,000 live births, respectively [8].
Emergency obstetric care coverage is poor (around 15%)
[5,7]. On the other hand, according to UN indicators,
there are enough referral centres equipped with functional
operating rooms. However, the quality of care in the refer-
ral centres is inadequate, as evidenced by high case fatality
rates (above 1%) [5,7].
Interventions to improve the performance of health 
professionals
The concept and techniques of continuous quality
improvement offer a variety of strategies to improve the
performance of health professionals [11]. These
approaches relate to complex interventions in which
health professionals are directly involved in analyzing and
modifying care processes to improve their performance
and the health outcomes of their patients.
A meta-analysis of educational outreach visits, including
69 randomized controlled trials, most of which were car-
ried out in industrialized countries, shows moderate
effects in terms of changing professional practices, with
considerable heterogeneity depending on professional
categories and contexts [12].
A meta-analysis of audit and feedback approaches that
reviewed 47 randomized controlled trials with more than
3,500 clinicians shows that this technique may be effec-
tive in improving medical practices. The baseline compli-
ance with recommended practice (prior to intervention)
and the intensity of audit and feedback are major factors
influencing the effectiveness of this technique [13].
In low-income countries, a systematic review of interven-
tions aimed at improving the performance of health pro-
fessionals suggests that: (i) simple dissemination of
written guidelines is often ineffective, (ii) supervision and
audit with feedback are generally effective, and (iii) mul-
tifaceted interventions might be more effective than single
interventions [9].
The ALARM (Advances in Labour and Risk Management)
International Program, or AIP, was developed by the Soci-Trials 2009, 10:85 http://www.trialsjournal.com/content/10/1/85
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ety of Obstetricians and Gynaecologists of Canada
(SOGC). It is based on a combination of two potentially
effective approaches for improving performance among
health professionals [14]: 1) educational clinically-ori-
ented and evidence-based outreach visits focused on the
principal causes of maternal mortality, and 2) facility-
based maternal death reviews or audits, as proposed by
WHO [15]. In 2005, we conducted a pilot study in Senegal
to analyze the feasibility of maternal death reviews in five
referral hospitals [16]. The results of this study confirm
that the majority (87%) of maternal deaths in referral hos-
pitals are attributable to direct obstetric causes, and three-
quarters of these can be avoided using locally-adapted
measures. The results also suggest that the involvement
and leadership of those in charge of maternity services
(physician and midwife) play a primordial role in imple-
menting audits. The capacity of those in charge of the serv-
ice to ensure such leadership depends on the following
key aptitudes: (i) knowledge of evidence-based practice
for the main obstetric complications; (ii) an understand-
ing of non-medical reasons for maternal death (social,
economic, cultural, and legal dimensions of maternal
mortality); and (iii) a mastery of the clinical audit
approach. We also showed, in another study carried out in
a district hospital in Senegal, that the routine conduct of
maternal death audits led to a reduction in maternal mor-
tality of 50% in year 3, in comparison with the pre-inter-
vention period [17].
What is not known
While the results of some observational studies carried
out in sub-Saharan Africa are promising enough [17-19],
we have no evidence regarding the effectiveness, in terms
of reducing maternal and perinatal mortality, of interven-
tions based on educational outreach visits and audits, nor
on their large-scale implementation. For reasons of cost
and availability of information, studies on maternal and
perinatal health interventions in developing countries are
based preferentially on process indicators rather than
health outcomes indicators [3-7].
From our pilot study in Senegal, the following questions
emerged: 1) Does the AIP promote the development of
local leadership? 2) Does the AIP produce changes in clin-
ical practice among the health professionals? 3) Do the
changes in practice have an effect, in the medium term, on
maternal and perinatal mortality? 4) Does the AIP have an
effect on staff satisfaction? 5) Can the intervention model
be modified to improve cost-effectiveness? The QUARITE
trial is an attempt to respond to these questions and to the
need for more evidence on the effectiveness and function-
ing of interventions aimed at reducing maternal and peri-
natal mortality and morbidity in developing countries.
Hypotheses
Our hypothesis is that the ALARM International Program
(AIP) reduces the overall rate of maternal mortality, as
measured in the hospitals in the post-intervention period,
by 30% in comparison with the control group. Secondary
hypotheses are that the AIP: 1) reduces the number of
stillbirths and early neonatal mortality; 2) reduces severe
maternal morbidity and the case fatality rate; 3) improves
the quality of care through better utilization of local
resources and changes in professional practices; and 4)
increases the satisfaction of health professionals.
Aims
The objective is to evaluate the effectiveness of the AIP in
reducing maternal mortality at referral hospitals in Mali
and Senegal, as well as improvements in perinatal health,
resource availability, service organization, medical prac-
tices, and the satisfaction of health personnel.
Design
This is an international, multi-centre, controlled cluster-
randomized trial of a complex intervention. To avoid con-
tamination bias between clinicians in the same service,
the unit of randomization and of intervention is the par-
ticipating healthcare facility.
Inclusion and exclusion criteria
The hospitals entered the trial in September 2007. The
study will be conducted in 46 out of a total of 49 eligible
referral hospitals—23 in Mali and 26 in Senegal—spread
across both countries. A hospital was eligible for the trial
if it had functional operating rooms and carried out more
than 800 deliveries annually. Three eligible hospitals were
excluded: two already had a structured program for carry-
ing out maternal death audits before the project began,
and for one other hospital, written consent was not pro-
vided by local authorities. The 46 included hospitals are
representative of the existing health system in Senegal and
Mali, taking into account the variety of the contexts
(urban versus rural) and of the levels of care (primary ver-
sus secondary referral health facilities).
The intervention directly targets health professionals
involved in obstetric care in the various participating hos-
pitals and, indirectly, the women who give birth in these
facilities. These health professionals are the staff who are
trained in labour and delivery management and the clini-
cal management of obstetric or neonatal complications:
physicians, midwives, obstetric nurses, nurse-anaesthet-
ists, and surgical assistants.
Inclusion criteria for women in the QUARITE study are 1)
being a patient who delivered in one of the participating
facilities, 2) between September 1, 2007, and August 31,Trials 2009, 10:85 http://www.trialsjournal.com/content/10/1/85
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2011. Exclusion criteria are 1) having delivered at home
or 2) in another centre, with postnatal transfer.
Intervention group activities
These activities started in September 2008 and will end in
August 2010. Professionals from the intervention group
have been trained in evidence-based practice using the
ALARM international course [14] that targets health pro-
fessionals who provide obstetrical care, reviewing the top
maternal killers and suggesting essential tools and prob-
lem management with the goal of improving care for
mothers and newborns. This course promotes evidence-
based practice, using data from up-to-date systematic
reviews of randomized trials. The course was developed
and is maintained and taught jointly by family physicians,
obstetricians, midwives, and nurses from developing
countries. It has the administrative support and backing
of the SOGC.
The sequence of activities during the two years is directed
toward developing local leadership and empowering
obstetric teams. To meet this objective, the intervention
will be carried out in several steps (Figure 1). The interven-
tion began with recruitment of opinion leaders in each
centre and their training in best practices and in maternal
death audits (training the trainers). The opinion leaders
will then create, in their own centres, obstetric teams
charged with implementing the maternal death audits
and will organize staff training in best practices with the
support of external facilitators (educational outreach vis-
its).
a) Training opinion leaders: The local opinion leaders are
those responsible for maternity services in the hospitals of
the intervention group (one physician and one midwife
per centre). In September 2008, the opinion leaders took
part in a six-day training session provided by three certi-
fied instructors. The session included three days of train-
ing in EmOC best practices, one day of training in
maternal death audit techniques, one day of awareness
training related to economic, sociocultural and ethical
barriers (including sexual and reproductive rights), and
one day of training in adult education methods. At the
end of the session, a normative evaluation was carried out.
No financial inducement was given to the health workers
involved in the program at the intervention sites.
b) Creating and training a multidisciplinary audit commit-
tee  (physicians, midwives, nurses, and administrators),
according to the following agenda: 1) identification and
training of data collectors on maternal deaths; 2) training
of committee members in the process of carrying out
audits; and 3) annual summary of audit results.
c) Launching the audit cycle: With the support of external
facilitators, the audit process will be set in motion by the
audit committee in each centre in accordance with the
approach proposed by WHO [15] (see Figure 2). Monthly
audit meetings are recommended to analyze cases of
maternal deaths in the facility.
d)Training qualified staff in best practices: The local opin-
ion leaders, supported by the external facilitators, will
train the professionals in each health facility according to
the following agenda: 1) evaluation of needs for best prac-
tices training; and 2) organization of between four and
eight training sessions in best practices during the inter-
vention period. The themes will be selected by local opin-
Key steps in the implementation of the ALARM International Program in each hospital of the intervention group Figure 1
Key steps in the implementation of the ALARM International Program in each hospital of the intervention 
group.
Step 1: Training opinion leaders 
One physician and one midwife, 
(service chiefs) per hospital 
Recertification after one year 
Step 3: 
Launching the 
audit cycle 
Step 4: Training 
qualified personnel in 
best practices 
Step 2: Creating and training a 
multidisciplinary audit committee  
Educational outreach visits by external facilitators Trials 2009, 10:85 http://www.trialsjournal.com/content/10/1/85
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ion leaders according to the principal causes of maternal
mortality that will be identified during maternal death
reviews.
d) Educational outreach visits by external facilitators: A
national opinion leader, chosen for his or her expertise
and leadership, and the AIP international coordinator will
visit all the hospitals in the intervention group every three
months. The purpose of these visits will be to support the
local opinion leaders in their role of providing AIP train-
ing to all the health professionals in the maternity service
and to ensure that audits are being carried out, particularly
by overseeing an audit meeting. To promote evidence-
based practice, meetings with the hospital's professionals
and administrators will be encouraged, as well as clinical
observation periods related to the themes that were
taught.
e) Recertification of the opinion leaders: One year after the
initial training (September 2009), the opinion leaders of
both countries will undergo an accelerated training ses-
sion together, led by certified instructors. The purpose of
this recertification session is to verify the opinion leaders'
knowledge, update them on the clinical content and proc-
ess of maternal death audits, discuss their roles, share their
experiences and confirm their capacity to provide leader-
ship in their clinical settings.
Control group
No external intervention is planned for this group.
Study endpoints
Endpoints will be measured including periods before (12
months), during (24 months), and after the intervention
(12 months). The main reason for the 12 month pre-inter-
vention data collection was to measure process and out-
come indicators during the baseline period and to control
the effect of the intervention for possible changes in these
indicators within the four-year study period.
The primary endpoint measure is the overall rate of mater-
nal mortality (number of maternal deaths among women
giving birth in the facility). The sample size was estimated
in order to ensure adequate statistical power to show sig-
nificant differences in maternal mortality among the
groups.
As secondary endpoints, we also defined three levels of
measurement for effectiveness of the intervention:
a) Indicators of resource availability: A systematic and
standardized inventory of available resources will be
undertaken each year. The hospital complexity index will
be calculated for each facility to reflect the availability of
different categories of resources required to provide high
quality emergency obstetric care [20]: basic services,
screening tests, basic emergency obstetric resources, intra-
partum care, general medical services, anaesthesiology
resources, human resources, academic resources, and clin-
ical protocols.
b) Indicators of quality of care: The clinical data collected
will allow us to measure the rates of essential obstetric
interventions considered effective in reducing maternal
and perinatal mortality: assisted deliveries (forceps and
vacuum extraction), caesarean sections, transfusions and
hysterectomies, transfers to other heath facilities. The
quality of care will also be evaluated on a sampling of
cases according to objective criteria for clinical manage-
ment (criterion-based clinical audit). Repeated satisfac-
tion surveys of the health personnel will allow us to
measure, on the one hand, the staff retention rate, and on
the other, changes in the level of satisfaction among pro-
fessionals. Staff movements will be monitored as part of
the health workers satisfaction study, for which we under-
take an annual census.
c) Maternal and perinatal health outcomes: The incidence
of maternal mortality will be measured, as well as its dis-
tribution among its principal causes: pre- and postpartum
hemorrhage, prolonged or dystocic labour, uterine rup-
ture, postpartum infection, pre-eclampsia/eclampsia. We
will also measure, in each facility, the case fatality rate, the
rate of stillbirths, and early neonatal mortality (during
hospitalization). We will monitor referrals in and out of
the facilities and track the mortality of mothers and babies
discharged from the institutions, using the existing infor-
mation systems (hospital registers and feedback from
referral institutions to the others) and calling the institu-
tions when the information is not available.
Audit of maternal deaths is the cornerstone of this com-
plex intervention. According to WHO [15], audit of mater-
Maternal death audit cycle in the hospitals Figure 2
Maternal death audit cycle in the hospitals. Source: 
Dumont et al [17].Trials 2009, 10:85 http://www.trialsjournal.com/content/10/1/85
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nal deaths should improve inter-personnel
communication, team working (and staff motivation),
resource availability, performance of health workers, and
quality of care. Training for the local opinion leaders and
parallel training for other staff in best practices should
reinforce the effects of the audit activities on health work-
ers' performance. The other components of the interven-
tion should facilitate the implementation of the program
using activities to support the actors (outreach visits). As
with other complex interventions, the synergy among all
components is expected to be effective. All these effects
will ultimately have an impact on maternal mortality (see
Figure 3). The effects of each component will be assessed
by measuring the process indicators: indicators for the
implementation of the program, and indicators of
resource availability and of quality of care.
Randomization and allocation
Centres were included on the basis of formal, informed
consent on the part of the hospital director and the person
in charge of maternity services. After a one-year pre-inter-
vention data collection phase, each hospital was ran-
domly assigned, in August 2008, to either an intervention
group, in which the AIP will be implemented, or a control
group.
The participating hospitals were stratified in six strata cor-
responding to the combination of two countries (Mali
and Senegal) and three hospital types: hospitals in the
capital, regional hospitals, and district hospitals outside
the capital. We attempted to ensure optimal balance
between the hospitals assigned to the intervention and the
control groups in terms of their number and size (number
of deliveries per year). Therefore, within each stratum, we
Outcomes of the trial Figure 3
Outcomes of the trial. *EmOC: Emergency obstetric care.
ALARM International Program 
Indicators for implementation 
Identification of opinion leaders 
Training in best practices 
Review of maternal deaths 
Implementation of recommendations 
Educational outreach visits by external facilitators 
Indicators of quality of care 
Essential obstetrical interventions 
Standard obstetric care according to 
the criterion-based clinical audit 
Satisfaction of health personnel 
Indicators of resource availability 
Basic services (water, electricity …) 
Essential laboratory tests 
Essential EmOC* equipment  
Intrapartum care services 
Specialized medical services 
Anaesthesia-resuscitation 
Human resources 
Care protocols 
Maternal and perinatal health outcomes 
Maternal mortality 
Maternal morbidity and case fatality 
Perinatal mortality Trials 2009, 10:85 http://www.trialsjournal.com/content/10/1/85
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first ranked the hospitals with respect to size, and then
used blocked randomization, with each block of size two
containing two hospitals with adjacent ranks, i.e., of sim-
ilar size (Figure 4). All participating hospitals were rand-
omized simultaneously, after their list was provided,
which eliminated any risk of allocation bias.
Data collection and management
Data collection
A system of data collection, independent of the AIP, was
set up in September 2007 in the 46 study hospitals. This
system is based on the WHO global survey on maternal
and perinatal health [20], which considers clinical data at
the individual level and organizational data at the facility
level. All deliveries carried out in the participating centres
are registered by local collectors (nurses or midwives
trained to do this). These collectors complete a standard
form for each eligible patient that includes information
on maternal characteristics, prenatal care, labour and
delivery, diagnosed complications, and the vital status of
both mother and child at discharge from hospital (see
patient registration form, Additional file 1). This informa-
tion is extracted from the hospital registers and from avail-
able medical records whose quality and archiving are
regularly monitored by the national coordinator of the
study. These data will be collected on an ongoing basis
throughout the study. With respect to facility-level data,
the national coordinator carries out an annual inventory
of the resources available in each hospital using a stand-
ardized grid, by visiting all the services of the hospitals
involved in EmOC.
To assess the quality of care, we will sample medical
records of 50 patients at each of the 46 participating cen-
tres using simple random sampling. An external evaluator
will assess each record using a criterion-based clinical
audit (CBCA) to obtain a score for quality of care. The
CBCA scores, ranging from 0 to 27, are then dichotomized
as standard (score equal to or greater than 22) versus sub-
standard (score below 22) care. The sample size of 50
records/centre will allow us to estimate the proportion of
patients receiving standard care in each centre with suffi-
cient precision. Specifically, the half-width of the 95%
confidence interval will not exceed 15%. The CBCA devel-
oped by the researchers of the QUARITE trial employs evi-
dence-based clinical criteria to ascertain if minimal
quality of care is provided to the patients sampled. These
criteria have been selected based on thorough review of
the literature and expert consensus and are consistent with
the WHO guidelines for conducting an obstetrical CBCA
Trial design Figure 4
Trial design. *The hospitals in each country's capital (Dakar in Senegal and Bamako in Mali) are characterized by a high level 
of obstetric activity (more than 3000 deliveries annually) and are easily accessible to the public because of their proximity. 
°Regional hospitals and district hospitals are outside the capitals. +Randomization by blocks of 2 in order to ensure a compara-
ble number of patients in both groups.
Mali 
22 hospitals, 531 trained professionals 
46,797 patients expected per year 
Senegal 
24 hospitals, 536 trained professionals 
50,144 patients expected per year 
6 hospitals 
in Dakar* 
10 regional 
hospitals°
8 district 
hospitals° 
6 hospitals in 
Bamako* 
4 regional 
hospitals°
12 district 
hospitals° 
3 intervention 
hospitals 
3 control 
hospitals 
5 intervention 
hospitals 
5 control 
hospitals 
4 intervention 
hospitals 
4 control 
hospitals 
3 intervention 
hospitals 
3 control 
hospitals 
2 intervention 
hospitals 
2 control 
hospitals 
6 intervention 
hospitals 
Stratified  
selection 
Random
+
allocation 
6 control 
hospitals Trials 2009, 10:85 http://www.trialsjournal.com/content/10/1/85
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(Beyond the numbers: Reviewing maternal deaths and
complications to make pregnancy safer. Geneva: World
Health Organization, 2004) [15].
Before, during, and after the intervention period, satisfac-
tion surveys will be conducted with all the health profes-
sionals in the participating centres; these will be done by
a research professional in individual interviews. We will
use a pre-tested questionnaire that contains 42 closed,
Likert-type questions. The questions on satisfaction relate
to remuneration, work tools and environment, work
organization and content, training and supervision, emo-
tional satisfaction, management style, and attitudes
toward change. As part of these surveys, staff censuses are
undertaken in all the health facilities included in the
study.
Data management
Patient records are collected by the national coordinator
during quarterly visits and transferred to the national
coordinating centre for double data entry using Epi-Info
2000 software. The electronic record, cleared of each quar-
ter's clinical data, is then transmitted to the trial's coordi-
nating centre at the University of Montreal and stored in a
secure location. The facility-level data and the data regard-
ing staff satisfaction are recorded separately. The different
databases are periodically verified by the data manager.
All information collected on patients, health profession-
als or facilities is confidential. Access to the clinical data-
base is restricted to the data manager until the end of the
study. Access to the other databases is restricted to the
coordinators and researchers responsible for the various
sections of the trial.
Quality control of data
The quality control of clinical data will be carried out in
three stages. The first stage corresponds to the quarterly
visits of the national coordinator. During these visits, the
coordinator verifies that the data collection is exhaustive
by comparing the number of eligible patients on the hos-
pital's birth register with the number of patient forms col-
lected. A complementary procedure is carried out to
monitor the thoroughness of data on maternal deaths,
which are generally under-registered in the maternity
ward, by identifying the eligible maternal deaths among
all the female deaths that occurred in the facility using the
various registries available: admissions, hospitalizations
(maternity and other services), operating rooms, and
morgue. On a random sample of patient forms, the coor-
dinator checks the quality of data collected. The comple-
tion rate will be estimated as the proportion of patient
forms that contain 100% of the following information:
date of entry, patient identification, date of discharge, and
vital status of the mother at the date of discharge. The con-
cordance rate will be estimated as the proportion of
patient forms whose information is concordant with the
hospital registers and medical records. Both the comple-
tion rate and the concordance rate are expected to be
above 75%. If the completion or concordance rate is
between 50% and 75%, the coordinator will check the
data quality on a new random sample of patient forms. A
completion or concordance rate of less than 50% will trig-
ger the verification of all patient forms. A second control
of missing or abnormal data will be carried out at the
national coordination centres before data entry. If neces-
sary, the missing information is obtained from the collec-
tors of each facility by telephone or fax. The third step is
carried out by the data manager after the data has been
entered and transmitted to the trial coordination centre.
An audit report of the database, including lists of duplica-
tions and missing or abnormal data, is sent quarterly to
the national coordination centres, which are responsible
for correcting any errors.
Statistical analysis plan
Sample size and power calculations
The formula for calculating the required number of
patients is that used for a cluster-randomized controlled
trial design [21]. The calculation is based on an overall
maternal mortality rate of 1.5% in the pre-intervention
phase and an expected reduction of 30% in maternal mor-
tality in the hospitals of the intervention group, in com-
parison with the control group. This rate was estimated as
an approximate average of stratum-specific rates, which
ranged from 0.3% to 2.7%, observed in Senegal in a pilot
study in 2004-2005 [16]. Taking into consideration a
minimum of 830 women included per hospital, the
number of patients required was calculated for an odds
ratio of 0.70 and for an intra-cluster correlation coefficient
(ρ) of 0.001. The value of 0.001 can be considered con-
servative given the results of the WHO global survey on
maternal and perinatal health [22]. The calculation shows
that a total of 38,205 patients and 46 hospitals (38,205/
830) allows us to achieve a power of 82% to detect a 30%
reduction in the overall rate of maternal mortality
between the two groups (OR = 0.70) with 2-sided signifi-
cance test at α = 0.05 and with ρ = 0.001 (ACluster-design®
2005, version 2.0, World Health Organization).
According to service statistics available for 2006 and col-
lected for the 46 hospitals in the study, the expected
number of deliveries is 96,941 (mean cluster size = 2300;
minimum = 830; maximum = 8600), 50,144 in Senegal
and 46,797 in Mali. We identified 1,067 trained profes-
sionals working in these facilities, 536 in Senegal and 531
in Mali.
Type of analysis and handling loss-to-follow-up
The acceptability of the various components of the AIP,
including maternal death audits, is high [16,23]. Never-
theless, it is possible that a few hospitals may decide to
withdraw from the study. For these hospitals, data collec-Trials 2009, 10:85 http://www.trialsjournal.com/content/10/1/85
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tion will continue until the end of the study, in accord-
ance with the commitment made by the hospital
authorities at the time of inclusion. These hospitals will
therefore not be excluded from the analysis. We will con-
duct intention-to-treat analyses: each patient will be ana-
lyzed in the hospital where she was admitted and each
hospital will be analyzed within the group to which it was
originally assigned by the randomization.
Statistical analyses
Binary outcome (maternal death) will be measured for
each woman included in the study, while the unit of ran-
domization and intervention is the hospital, to avoid con-
tamination bias. A first descriptive analysis will allow us
to verify, in the pre-intervention phase, the comparability
of the groups in terms of the characteristics of the centres
and of the patients included. The primary analyses will
take into account the inter- and intra-cluster variability
and adjust the intervention effect for stratification varia-
bles (country and hospital type). To adjust the estimate of
variance in the intervention's effect on the interdepend-
ence of the events measured (maternal death or not)
among the patients of a given hospital, we will use the
Generalized Estimating Equations (GEE) approach which
generalizes logistic regression to cluster data [24]. The
interchangeable structure of the residual covariance
matrix will be used to represent intra-cluster correlations.
In secondary analyses, we will use the multivariable GEE
model to adjust the effect of the intervention for those
patient-level or hospital-level variables that show a
marked imbalance between the two arms of the trial. The
same approach will be used for secondary assessment cri-
teria. In all the analyses, the effect of the intervention will
be estimated using the odds ratio (95% CI) from the GEE
model and tested by one-tailed Wald testing (α = 0.05)
[24].
The preliminary analyses will verify whether the interven-
tion's effect varies according to country using the likeli-
hood ratio chi-square test with one degree of freedom for
country-intervention interaction. If the test does not reject
the null hypothesis at α = 0.05, the interaction will be
eliminated from the final model, which will allow us to
assess the overall effect of the intervention. On the other
hand, if the interactions are statistically significant, the
sub-group analyses will assess the effects of the interven-
tion separately for each country, with a power less than
90%. A similar approach will be used to test whether the
effect of the intervention depends: (i) on the overall rate
of maternal mortality in the pre-intervention phase (Year
1); (ii) on changes in maternal mortality within the inter-
vention period; or (iii) on hospital type.
Economic evaluation
The economic analysis has two components. First, an
incremental analysis will be undertaken to evaluate the
cost per life saved in each of the hospital strata. Second, a
simulation will be conducted of the overall benefits and
marginal costs of a hypothetical scaling up of the maternal
audit intervention at the national level. Costs include
both direct costs of the intervention (employees, consum-
ables, equipment, overheads, and capital costs) and costs
incurred by other units and patients, following changes in
the practices of the newly trained professionals. Key
parameters of the analysis, such as activities and resources
mobilized for the intervention, real prices, attribution
rules for capital costs and overheads, and unit costs in
each hospital stratum, will be determined during a pre-
liminary survey. The measurement of costs will be based
on project cost-sheets, reports, budgets, and interviews.
Multiway sensitivity analysis will be performed to assess
robustness of the results.
Potential limitations of the trial
Although there is no "intervention", the activity related to
data collection may have an impact on quality improve-
ment and maternal outcomes in the control group. How-
ever, this "data collection" effect is a priori similar in the
two groups (intervention versus control). The results of
our trial may be contaminated if hospital staff transfer
from centres randomized to an active intervention group
into other centres included in the control group. Such
contamination would attenuate the apparent effectiveness
of the intervention. To assess the extent of such potential
contamination, we will keep track of all transfers of the
hospital staff involved in the trial between the study cen-
tres. Up to now (end of Year 1), the rate of personnel
transfers is low (less than 1%). Informal data obtained
from interviews with the personnel during the coordinat-
ing visits suggest that most of the staff in the active-inter-
vention centres do not want to be transferred before the
end of the trial, which should limit the risk and the extent
of such potential contamination. Furthermore, imple-
mentation of the AIP requires sustained teamwork
unlikely to be assumed by isolated individuals.
Ethical issues
Ethic committee approvals
The trial has been approved by the ethics committee of
Sainte-Justine Hospital in Montreal, Canada, which man-
ages the operating funds, and by the national ethics com-
mittees in Senegal and in Mali. The QUARITE trial is
registered on the Current Controlled Trials website under
the number ISRCTN46950658 http://www.controlled-tri
als.com/.
Informed consent and information sheet
The participating hospitals were included on the basis of
informed consent by the local authorities (director of the
centre and chief of maternity services). The authorities
were informed that 1) all centres had the option of with-
drawing from the project at any time; 2) the AIP trainingTrials 2009, 10:85 http://www.trialsjournal.com/content/10/1/85
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Administrative structure for the trial Figure 5
Administrative structure for the trial. *SOGC: Society of Obstetricians and Gynaecologists of Canada.
Intervention 
1 Program coordinator
3 National instructors 
Evaluation 
Coordination Centre - Senegal
1 National coordinator for collection of clinical 
and organizational data 
24  Clinical data collectors (one per centre) 
2 Data entry operators 
1 Collector of satisfaction data 
Coordination Centre - Mali 
2 National coordinators for collection of 
clinical and organizational data 
22 Clinical data collectors (one per centre) 
2 Data entry operators (duplicate entries) 
ALARM/SOGC Committee*
6 Certified instructors 
ALARM Committee -  Senegal
1 Facilitator (one of the above)
ALARM Committee - Mali
3 National instructors 
1 Facilitator (one of the above)
Trial steering committee 
1 Trial Coordinator 
1 Data Manager
1 Coordinator for the satisfaction survey + research assistants 
1 Coordinator for the economic evaluation + research assistants 
1 Collector of satisfaction data 
Local audit committee (hospital)
23 Local opinion leaders 
23 Collectors of information on 
maternal deaths 
1 ALARM Committee chairman 
Trial Coordination Centre - Canada
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would be offered to the control group hospitals at the end
of the study if the intervention proved to be effective; and
3) data collection would continue until the end of the
study, even for centres that withdraw from the study. Con-
sent was also obtained from staff who participated in the
satisfaction surveys. Collection of clinical data from hos-
pital registers and medical records is authorized by the
hospital authorities and does not require patient consent
[20].
Interim analyses and stopping rules
An independent data security and monitoring committee
(DSMC) was established, made up of three international
experts in epidemiology and biostatistics, reproductive
health research, and obstetrics and gynaecology in
resource-poor settings. Its primary responsibility will be to
ensure the security of the trial and to monitor the progress
of the research according to the established protocol. The
committee could decide to stop the trial for the following
reasons: if the AIP is proven effective by the end of the first
year of intervention; if the quality of the data is inade-
quate; if the level of implementation of the AIP among the
hospitals in the intervention group is too low; if there is
significant contamination of the control group; if there is
fraud; if there is any new information that would lead to
the conclusion that the trial is unnecessary, useless, or
even unethical. To assess the effectiveness of the interven-
tion at the end of the first year of intervention, an interme-
diate analysis will be planned using Peto criteria (α =
0.001), which ensure a total type I risk of error, for the
final analysis, of 0.05. If, based on the results of this
interim analysis, the DSMC decides to discontinue the
trial, we will continue long-term follow-up to monitor the
implementation of the program and the reduction of
maternal mortality in the two groups (intervention and
control).
Sponsor and project administration
The project was approved by the Canadian Institutes of
Health Research (CIHR) and funded in January 2007. The
trial began in September 2007 in Senegal and in Novem-
ber 2007 in Mali. The funds are managed by Sainte-Justine
Hospital of the University of Montreal. The multidiscipli-
nary committee is made up of Canadian, Senegalese, and
Malian researchers with expertise in public health, mater-
nal and perinatal health, clinical research, medical teach-
ing, and biostatistics, with a strong global health
orientation. The collaborating centres in Senegal and
Mali, specializing in large-scale data collection and entry,
are also involved in the study. The ALARM International
Program will be coordinated by the SOGC in collabora-
tion with the Ministry of Health, the Faculty of Medicine
and the professional associations (gynaecologists-obste-
tricians and midwives) of each country. The project's
administrative structure is presented in Figure 5. The mon-
itoring of the intervention and evaluation components is
carried out by the trial coordinator, who reports regularly
to the steering committee.
The trial steering committee meets twice a year to oversee
the implementation of the ALARM International Program
in the intervention group, follow the data collection proc-
ess, monitor data quality, coordinate the intermediate sta-
tistical analyses, consider the conclusions of the
independent committee on data security and monitoring,
and coordinate the economic evaluation.
Start date: September 1, 2007
Intervention period: September 1, 2008 to August 31,
2010
End date: August 31, 2011
Reporting date: January 1, 2012
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